FDA Panel Rejects Use of MDMA for Treatment of PTSD
An independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder. [Source]
Publication Date:Origin: nytimes.com
Category: Psychedelic and Hallucinogenic Drugs
Topics: disorder, stress, post-traumatic, treatment, risks, outweigh, trials, clinical, concerns, expressed, experts, group, independent, Treatment, Rejects, Panel
Source: https://www.nytimes.com/2024/06/04/health/fda-mdma-therapy-ptsd.html